BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 230 filers reported holding BEAM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,537,636 | -26.2% | 105,515 | -2.0% | 0.04% | -17.0% |
Q2 2023 | $3,439,244 | +4.2% | 107,712 | -0.1% | 0.05% | -14.5% |
Q1 2023 | $3,301,173 | -21.9% | 107,811 | -0.3% | 0.06% | -30.4% |
Q4 2022 | $4,228,417 | -25.6% | 108,116 | -9.3% | 0.08% | -20.2% |
Q3 2022 | $5,680,000 | +11.4% | 119,221 | -9.5% | 0.10% | +8.8% |
Q2 2022 | $5,101,000 | -43.5% | 131,777 | -16.4% | 0.09% | +9.6% |
Q1 2022 | $9,031,000 | -27.4% | 157,609 | +0.9% | 0.08% | +16.9% |
Q4 2021 | $12,442,000 | -5.6% | 156,131 | +3.0% | 0.07% | +4.4% |
Q3 2021 | $13,186,000 | -29.0% | 151,546 | +5.1% | 0.07% | -25.3% |
Q2 2021 | $18,562,000 | +61.2% | 144,219 | +0.2% | 0.09% | +46.8% |
Q1 2021 | $11,518,000 | +8.8% | 143,900 | +10.9% | 0.06% | +17.0% |
Q4 2020 | $10,590,000 | +304.8% | 129,711 | +22.1% | 0.05% | +231.2% |
Q3 2020 | $2,616,000 | +2.5% | 106,263 | +16.6% | 0.02% | -20.0% |
Q2 2020 | $2,551,000 | +57.8% | 91,105 | +1.4% | 0.02% | +5.3% |
Q1 2020 | $1,617,000 | – | 89,813 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |